Literature DB >> 12911867

The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever.

Y Akcan1, Y Bayraktar, S Arslan, D H Van Thiel, B C K Zerrin, O Yildiz.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by recurrent fever of unknown origin, renal amyloidosis, peritonitis, pleuritis and/or synovitis. There have been many studies to elucidate the etiopathogenesis of FMF. IL-6 is a cytokine that can induce the formation of serum amyloid A and C-reactive protein, both of which are important in development of amyloidosis. IL-6 was determined to be strongly associated in the etiopathogenesis of periodic fever in Chinese-pei dogs. The dogs with this syndrome experience periodic fever, arthritis, renal amyloidosis, a clinical picture very alike of human FMF. Here, we aimed to study mainly whether IL-6 had a similar etiopathogenetic role in human FMF as in Chinese-pei dogs syndrome. The median IL-6 blood levels were found to be higher in patients with acute (n=8) FMF attack (1.85 U/ml) compared to those (n=33) with asymptomatic ones (1.0 U/ml) (p=0.16). There are mainly two results: first; the study should be designed with a larger sample size of patients with acute attack in order to alleviate underestimation of significance, second; sampling time may give various results because of dynamic changes of cytokine levels during acute attack period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911867

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  5 in total

Review 1.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

2.  Does immune activation continue during an attack-free period in familial Mediterranean fever?

Authors:  U Musabak; A Sengul; C Oktenli; S Pay; Z Yesilova; L Kenar; S Y Sanisoglu; A Inal; A Tuzun; A Erdil; S Bagci
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

3.  Melatonin and its day and night rhythm of alterations in familial mediterranean Fever: a brief research letter.

Authors:  Ugur Musabak; Guldem Kilciler; Ahmet Uygun; Murat Kantarcıoglu; Zulfukar Polat; Rahsan I Sagkan; Sait Bagci
Journal:  Open Rheumatol J       Date:  2011-02-04

4.  Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever.

Authors:  Tomohiro Koga; Kiyoshi Migita; Shuntaro Sato; Masataka Umeda; Fumiaki Nonaka; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Yukitaka Ueki; Junya Masumoto; Kazunaga Agematsu; Akihiro Yachie; Koh-Ichiro Yoshiura; Katsumi Eguchi; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 5.  Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.

Authors:  Serdal Ugurlu; Aysa Hacioglu; Yasaman Adibnia; Vedat Hamuryudan; Huri Ozdogan
Journal:  Orphanet J Rare Dis       Date:  2017-05-30       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.